Giri Ramsingh

Company: Gilead Sciences
Job title: Executive Director
Seminars:
Discussing Efficacy & Safety Data for CD47-Targeting Therapy 12:00 pm
• Sharing patient outcomes, toxicology studies, and dose escalation rationale • Considering the safety concerns of a ubiquitously expressed target such as CD47, and the toxicity seen in the clinic • Translating CD47 therapies to show targeting and validation of targetsRead more
day: Day Two